Neurocutaneous melanoma in association with giant congenital melanocytic nevi in a child (Touraine syndrome) – A dermatoradiological correlation
How to cite this article: Puthiyakam J, Riyaz N, Arakkal FR, Arakkal R. Neurocutaneous melanoma in association with giant congenital melanocytic nevi in a child (Touraine syndrome) – A dermatoradiological correlation. J Skin Sex Transm Dis 2021;3(1):84-6.
Touraine syndrome or neurocutaneous melanosis/melanoma is a rare melanophakomatosis characterized by extensive/multiple congenital melanocytic nevi associated with cerebral/meningeal melanosis or melanoma. We report a 12-year-old boy with a congenital giant melanocytic nevus on the bathing trunk distribution with scattered lesions on the face, neck, and legs. MRI brain revealed a melanoma in the right amygdala.
Congenital giant melanocytic nevus
Touraine syndrome or neurocutaneous melanosis/melanoma (NCM) is a rare, non-familial, condition described by Rokitansky in 1861.[1-3] The diagnostic criteria include multiple (three or more) or large congenital nevi (measuring 9 cm or more on the scalp or 6 cm or more on the body) with melanin-containing cells in the leptomeninges (melanosis or melanoma). Giant congenital melanocytic nevi (GCMN) occur in approximately 1/20,000 of live births. The prognosis is bad when neurological manifestations appear. Central nervous system (CNS) involvement is established by MRI.
A 12-year-old boy presented with focal seizures lasting for a few seconds of 2 months duration. He had a large pigmented nevus around the lower trunk since birth. He did not have any neurological deficits. Dermatological examination revealed a giant melanocytic nevus around the lower trunk (size 52 × 30 cm). There were multiple similar smaller circumscribed nevi of size varying from a few millimeters to several centimeters on the right scapular region, anterior chest wall, the right side of the forehead, [Figure 1a-c] left mastoid region, and right leg. MRI brain revealed a curvilinear T1 and T2 hyperintense 20 × 2 mm lesion which was not suppressed in T1-weighted fat-suppressed sequence in the amygdala of the right temporal lobe consistent with brain melanoma [Figure 2a-c].
The diagnostic criteria, which were first described by Fox and later revised by Kadonaga and Frieden in 1991, include the combination of the following: A single giant congenital nevus (measuring at its greatest diameter ≥20 cm in adults or ≥9 cm on the head or ≥6 cm on the trunk in neonates and infants) or multiple (three or more) congenital nevi, accompanied by meningeal melanosis or CNS melanoma. CNS involvement includes parenchymal or leptomeningeal lesions such as melanosis (aggregation of benign melanocytic cells) or melanomas. Patients with large cutaneous lesions, particularly over the back, neck, or scalp and multiple (more than three) nevi, have a greater risk for neural involvement.
MR imaging findings of NCM show hyperintense T1 signal within the brain parenchyma and leptomeninges due to the paramagnetic effects of stable free radicals within melanin. The parenchymal foci are most commonly found in the anterior temporal lobes, specifically the amygdala, but may also be seen in the cerebellar hemispheres, dentate nuclei, basal ganglia, thalami, and pons.[8-10]
Patients with GCMN are at risk for NCM and those with GCMN on the posterior axis or in conjunction with many satellite melanocytic nevi have the greatest risk. The presence of large numbers of satellite nevi is the most important risk factor for NCM in patients with LCMN.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Conflicts of interest
Dr. Najeeba Riyaz is on the editorial board of the Journal.
- AJNR Am J Neuroradiol. 1995;16:603-6.MR of parenchymal neurocutaneous melanosis.
- [Google Scholar]